The company said the FDA gave it a 510(k) clearance for the use of Propeller, which combines sensors attached to inhalers with an app, with AstraZeneca’s Symbicort, for patients with asthma and COPD.

LEAVE A REPLY

Please enter your comment!
Please enter your name here